Nurix Therapeutics (NRIX) Competitors

Nurix Therapeutics (NASDAQ:NRIX) and Elanco Animal Health (NYSE:ELAN) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their community ranking, institutional ownership, profitability, media sentiment, earnings, risk, dividends, valuation and analyst recommendations.

Which has better valuation & earnings, NRIX or ELAN?

Nurix Therapeutics has higher earnings, but lower revenue than Elanco Animal Health. Nurix Therapeutics is trading at a lower price-to-earnings ratio than Elanco Animal Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nurix Therapeutics	$76.99M	19.49	-$143.95M	-$2.91	-7.28
Elanco Animal Health	$4.45B	1.37	-$1.23B	$0.40	30.78

Do institutionals & insiders believe in NRIX or ELAN?

97.5% of Elanco Animal Health shares are owned by institutional investors. 7.2% of Nurix Therapeutics shares are owned by insiders. Comparatively, 0.6% of Elanco Animal Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Does the media prefer NRIX or ELAN?

In the previous week, Nurix Therapeutics had 7 more articles in the media than Elanco Animal Health. MarketBeat recorded 10 mentions for Nurix Therapeutics and 3 mentions for Elanco Animal Health. Elanco Animal Health's average media sentiment score of 0.87 beat Nurix Therapeutics' score of 0.72 indicating that Elanco Animal Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Nurix Therapeutics	4 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive
Elanco Animal Health	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do analysts rate NRIX or ELAN?

Nurix Therapeutics currently has a consensus price target of $30.35, indicating a potential upside of 43.31%. Elanco Animal Health has a consensus price target of $16.75, indicating a potential upside of 36.07%. Given Nurix Therapeutics' stronger consensus rating and higher probable upside, equities analysts plainly believe Nurix Therapeutics is more favorable than Elanco Animal Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nurix Therapeutics	0 Sell rating(s)	1 Hold rating(s)	16 Buy rating(s)	0 Strong Buy rating(s)	2.94
Elanco Animal Health	1 Sell rating(s)	4 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.33

Which has more volatility and risk, NRIX or ELAN?

Nurix Therapeutics has a beta of 2.11, indicating that its share price is 111% more volatile than the S&P 500. Comparatively, Elanco Animal Health has a beta of 1.41, indicating that its share price is 41% more volatile than the S&P 500.

Does the MarketBeat Community favor NRIX or ELAN?

Elanco Animal Health received 62 more outperform votes than Nurix Therapeutics when rated by MarketBeat users. However, 78.95% of users gave Nurix Therapeutics an outperform vote while only 54.37% of users gave Elanco Animal Health an outperform vote.

Company	Underperform	Outperform
Nurix Therapeutics	Outperform Votes 75 78.95%	Underperform Votes 20 21.05%
Elanco Animal Health	Outperform Votes 137 54.37%	Underperform Votes 115 45.63%

Is NRIX or ELAN more profitable?

Elanco Animal Health has a net margin of 4.60% compared to Nurix Therapeutics' net margin of -313.65%. Elanco Animal Health's return on equity of 6.78% beat Nurix Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nurix Therapeutics	-313.65%	-63.39%	-41.82%
Elanco Animal Health	4.60%	6.78%	3.03%

Summary

Nurix Therapeutics and Elanco Animal Health tied by winning 9 of the 18 factors compared between the two stocks.